Home
Conditions
Pharyngeal Neoplasms

Clinical trial condition

Pharyngeal Neoplasms

Explore clinical trials studying Pharyngeal Neoplasms. Study availability and eligibility vary by location and protocol.

734 public trials 231 recruiting studies

Refine in advanced search Browse all conditions

Pharyngeal Neoplasms trial results

Active, Not Recruiting

GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma

NCT03840421

Conditions: Carcinoma, Head and Neck Neoplasm, Head and Neck Neoplasms, +12 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Prognostic Value of CD4/CD8 Ratio in Patients with Nasopharyngeal Carcinoma

NCT06762470

Conditions: Carcinoma, Head and Neck Neoplasms, Histopathological Diagnosis of Nasopharyngeal Carcinoma, +13 more
Locations: Jiangxi Cancer Hospital Nanchang, Jiangxi, China

View Trial Details

Active, Not Recruiting

Irinotecan Liposomes in Combination With Nituzumab for the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of First-Line or Higher Immunotherapy

NCT06414577

Conditions: Head and Neck Neoplasms, Nasopharyngeal Cancer, Nasopharyngeal Diseases, +8 more
Locations: SunYat-senU Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Maintenance Therapy With Toripalimab Combined With Capecitabine/Placebo for Recurrent and Metastatic Nasopharyngeal Carcinoma

NCT05869227

Conditions: Carcinoma, Head and Neck Neoplasms, Maintenance Therapy, +12 more
Locations: SunYat-senU Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer

NCT04576091

Conditions: Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +52 more
Locations: Los Angeles General Medical Center Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

Northwestern University Chicago, Illinois, United States

University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States

View Trial Details

Active, Not Recruiting

The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

NCT02460887

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Bevacizumab and Pembrolizumab Combination in Platinum-resistant Recurrent/Metastatic NPC

NCT03813394

Conditions: DNA Virus Infections, Epstein-Barr Virus Infections, Head and Neck Neoplasms, +15 more
Locations: National University Hospital Singapore

View Trial Details

Active, Not Recruiting

Long-term Outcomes of Early-stage Nasopharyngeal Carcinoma Patients Treated with Radiotherapy Alone

NCT06612697

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +14 more
Locations: Taichung Veterans General Hospital Taichung, Taiwan

View Trial Details

Active, Not Recruiting

Distribution of Bacteria in OME After Radiotherapy For NPC.

NCT06523933

Conditions: Carcinoma, Ear Diseases, Head and Neck Neoplasms, +16 more
Locations: Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Penpulimab Combined With GP ± Anlotinib as Neoadjuvant Therapy in Locoregionally Advanced Nasopharyngeal Carcinoma

NCT05193617

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Hai Qiang Mai Guangzhou, Guangdong, China

View Trial Details

Pharyngeal Neoplasms

Pharyngeal Neoplasms trial results

Related conditions